These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 4732446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immunotherapy of proliferative hemocytopathies by transplantation of thymus from myasthenic patients].
    Rzepecki WM, Aleksandrowicz J, Szmigiel Z, Turowski G, Lukasiewicz M, Skotncki A, Lisiewicz J.
    Pol Tyg Lek; 1973 Nov 19; 28(47):1837-40. PubMed ID: 4771535
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Letter: Thymus transplantation in leukaemia and malignant lymphogranulomatosis.
    Rzepecki WM, Lukasiewicz M, Aleksandrowicz J, Szmigiel Z, Skotnicki A, Lisiewicz J.
    Lancet; 1974 May 18; 1(7864):990. PubMed ID: 4133676
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Graft of fetal thymus in Hodgkin's disease and in other malignant neoplasms].
    Ringenbach MG.
    Bord Med; 1970 Apr 18; 3(4):1009-10 passim. PubMed ID: 5422389
    [No Abstract] [Full Text] [Related]

  • 7. Thymus transplantation in leukaemia and malignant lymphogranulomatosis.
    Rzepecki WM, Lukasiewicz M, Aleksandrowicz J, Szmigiel Z, Skotnicki A, Lisiewicz J.
    Lancet; 1973 Sep 01; 2(7827):508. PubMed ID: 4125031
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of implantation of human embryonic thymus tissue in Hodgkin's disease].
    Veskova TK, Lichinitser MR, Astrakhan VI, Svet-Moldavskiĭ GIa.
    Vopr Onkol; 1971 Sep 01; 17(8):58-61. PubMed ID: 5134101
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Letter: Implantation of fetal thymus during the terminal period of Hodgkin's disease. Immunologic and histological data].
    Lang JM, Oberling F, Lacroute JM, Mayer S, Brettes PH.
    Nouv Presse Med; 1975 Feb 15; 4(7):509. PubMed ID: 1079342
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Myasthenia gravis and thymic Hodgkin's disease associated in one patient with familial lymphoproliferative disorders.
    Padua L, Palmisani MT, Di Trapani G, Evoli A, Larrocca LM, Tonali P.
    Clin Neuropathol; 1994 Feb 15; 13(5):292-4. PubMed ID: 7805314
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H, Konopka L, Karpowicz M, Sylwestrowicz T, Maślanka K, Arczyńska-Brojer E, Cieśluk S, Małkowska-Zwierz W, Pawelski S.
    Arch Immunol Ther Exp (Warsz); 1981 Feb 15; 29(6):739-55. PubMed ID: 7349093
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.